Christine A. Carberry serves as Executive at KERYX BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Christine A. Carberry has executed 8 insider transactions totaling $103.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 12, 2018 involved selling 100,646 shares valued at $0.
Christine A. Carberry currently holds 100,646 shares of KERYX BIOPHARMACEUTICALS INC (KERX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christine A. Carberry has been a net seller of KERX stock. They have purchased $0 and sold $103.3K worth of shares.
Christine A. Carberry's most recent insider trade was on Dec 12, 2018, when they sold 100,646 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.22 |
| Discretionary |
| Oct 18, 2018 | KERX | $6.7K | Sale | 2,040 | $3.29 | Discretionary |
| Jul 18, 2018 | KERX | $9.1K | Sale | 2,021 | $4.49 | Discretionary |
| Apr 18, 2018 | KERX | $9.8K | Sale | 2,026 | $4.83 | Discretionary |
| Mar 20, 2018 | KERX | $0 | Award | 41,250 | $N/A | Discretionary |
| Jan 18, 2018 | KERX | $44.1K | Sale | 9,048 | $4.87 | Discretionary |
| Jan 17, 2017 | KERX | $0 | Award | 85,000 | $N/A | Discretionary |